The Week in Review: March 9 – March 16, 2018

Friday, March 16, 2018 News Recap: Canada: Treatment: Fantastic news from both BC and Quebec this last week:  All restrictions to treatment under the respective provincial PharmaCare plans have been removed!! See Chronic hepatitis C medication now available for all British Columbians, and Quebec Expands Patient Access to Chronic Hepatitis C Therapies. Grants Awarded to 13 Canadian Initiatives to Help Advance the Goal of Eliminating Chronic Hep...

Grants Awarded to 13 Canadian Initiatives to Help Advance the Goal of Eliminating Chronic Hepatitis C Infection in High-Risk Populations

MISSISSAUGA, ON, March 14, 2018 /CNW/ - In support of Canada's commitment to the World Health Organization's (WHO) goal of eliminating chronic hepatitis C infection by 2030, Gilead Sciences Canada, Inc. (Gilead Canada) today announced a series of grants to support screening and linkage to care projects across Canada. These initiatives will focus on hepatitis C screening within high-risk patient populations and linking diagnosed patients to care. In total,

URGENT REQUEST FOR YOUR INPUT into a new HCV drug, SOFOSBUVIR

On October 1, 2013 the Canadian Agency for Drugs and Technologies in Health (CADTH) released a call for patient input into Gilead Science's new HCV drug, SOFOSBUVIR. In order to prepare our Patient Group submission by CADTH's October 23rd (noon, PST) deadline, HepCBC is ASKING for INPUT from HCV+ people and caregivers from throughout Canada, by Sunday, October 20th (midnight, PST). CLICK HERE to ADD YOUR VOICE to HepCBC's group submission which will help d